Nicolas Kumar

Nicolas Kumar

Auto-generated profile, based on publicly available information

Nicolas Kumar

Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
NKNicolas Kumar
Nicolas Kumar
MFMichael G. Fitzsimons
Michael G. Fitzsimons
MIManoj H. Iyer
Manoj H. Iyer
MEMichael Essandoh
Michael Essandoh
JKJulia E. Kumar
Julia E. Kumar
ABAmit Bardia
Amit Bardia

22 June 2023 in Seminars in Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
NKNicolas Kumar
Nicolas Kumar
JMJustin Mitchell
Justin Mitchell
ASAndrew Siemens
Andrew Siemens
SDSelina Deiparine
Selina Deiparine
DSDaniel Saddawi-Konefka
Daniel Saddawi-Konefka
DHDavid Hao
David Hao
Background. The EZ-Blocker is the newest generation of bronchial blocker and offers a potential alternative to left-sided double lumen tubes for lung isolation and one-lung ventilation during thoracic surgery. Methods. Databases were searched for randomized controlled trials comparing left-sided double lumen tube to the EZ-Blocker for one-lung ventilation during thoracic surgery. The time for placement, incidence of intraoperative displacement, and surgeons’ rating of lung collapse quality were designated as coprimary outcomes. The safety profiles of the two devices, including the incidence of airway trauma and post-extubation discomfort were also examined. Results. Six randomized controlled trials (495 patients) were analyzed. Compared to the EZ-Blocker, the left-sided double lumen tube was faster to place by a weighted mean difference of [95% CI] of −61.24 seconds [−102.48, −20.00] (P = .004) and was much less likely to become displaced during lung isolation with an odds ratio [95% CI] of .56 [.34, .91] (P = .02). The left-sided double lumen tube and the EZ-Blocker provided similar surgeon-rated quality of lung isolation. Although the left-sided double lumen tube caused a greater degree of post-extubation sore throat, there was a similar incidence of carinal trauma and post-extubation hoarseness compared to the EZ-Blocker. Conclusion. Our analysis suggests that the left-sided double lumen tube can be placed more quickly and is less prone to intraoperative displacement compared to the EZ-Blocker; the quality of lung collapse is similar. Thus, evidence appears to support the continued utilization of the left-sided double lumen tube for routine thoracic surgery requiring one-lung ventilation.

6 May 2023 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
NKNicolas Kumar
Nicolas Kumar
GRGrace R. Rahman
Grace R. Rahman
SFSamuel Falkson
Samuel Falkson
SLShu Yang Lu
Shu Yang Lu
ADAdam Dalia
Adam Dalia

24 December 2020 in Seminars in Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
NKNicolas Kumar
Nicolas Kumar
JKJulia E. Kumar
Julia E. Kumar
NHNasir Hussain
Nasir Hussain
LGLeonid Gorelik
Leonid Gorelik
MEMichael K. Essandoh
Michael K. Essandoh
MIManoj H. Iyer
Manoj H. Iyer
Background: New or worsened mitral regurgitation (MR) is an uncommon yet serious complication after surgical aortic valve replacement (SAVR). While there have been numerous reports of its occurrence, there is little consensus regarding its presentation and management. This systematic review summarizes the evidence in the current literature surrounding new or worsened MR after SAVR and analyzes its potential implications. Methods: Databases were examined for all articles and abstracts reporting on new or worsened MR after SAVR. Data collected included number of patients studied; patient characteristics; incidences of new or worsened MR; timing of diagnosis; and treatment. Results: Thirty-six full-text citations were included in this review. The prevalence of new or worsened MR after SAVR was 8.4%. Sixteen percent of new MR occurrences were from an organic etiology, and 83% of new MR occurrences were that of a functional etiology. Most diagnoses were made in the late or unspecified postoperative period using echocardiography (range: 0 minutes to 18 years postoperatively). While no patients died from this complication, 7.7% of patients (16 out of 207) required emergent procedural re-intervention. Conclusions: This systematic review underscores the importance of identifying new or worsened MR following SAVR and accurate scoring of MR severity to guide treatment. It also outlines the associated clinical measures commonly documented following this complication, and the usefulness of transesophageal echocardiography for the detection of significant MR. These results reflect the current, limited state of the literature on this topic and warrant further investigation into MR detection and management strategies in SAVR patients.

5 January 2025 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
NKNicolas Kumar
Nicolas Kumar
CTChihiro Toda
Chihiro Toda
ECEtienne J. Couture
Etienne J. Couture
GVGus J. Vlahakes
Gus J. Vlahakes
MFMichael G. Fitzsimons
Michael G. Fitzsimons

5 November 2025 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
NKNicolas Kumar
Nicolas Kumar
ABAmit Bardia
Amit Bardia
JOJamel P. Ortoleva
Jamel P. Ortoleva